Abstract
Adrenocortical tumors are neoplasms that rarely occur in pediatric patients. Adrenocortical carcinoma (ACC) is even more uncommon, and is an aggressive malignancy with 5-year survival of 55% in a registry series. There is a lack of information on long-term endocrine outcome in survivors. We describe a 10-year follow-up in a patient who presented at 3 years 5 months with a 1-year history of axillary odor and 6 months’ history of pubic hair development with an increased clitoral size. Androgen levels were increased and a pelvic sonogram revealed a suprarenal mass of the left kidney. The tumor was successfully removed. At 6 years 11 months, androgen levels increased again. Workup for tumor recurrence was negative and the findings likely represented early adrenarche. The patient had menarche at an appropriate time and attained a height appropriate for her family.
References
1. Ribeiro RC, Figueiredo B. Childhood adrenocortical tumours. Eur J Cancer 2004;40:1117–26.10.1016/j.ejca.2004.01.031Search in Google Scholar
2. Mcateer JP, Huaco JA, Gow KW. Predictors of survival in pediatric adrenocortical carcinoma: a surveillance, epidemiology, and end results (SEER) program study. J Pediatr Surg 2013;48:1025–31.10.1016/j.jpedsurg.2013.02.017Search in Google Scholar
3. Magro G, Vecchio GM, Alaggio, R. Diagnosis and prognosis of pediatric patients with adrenocortical carcinoma. In: Hayat M, editor. Pediatric cancer, volume 4, diagnosis, therapy, and prognosis. Dordrecht, NL: Springer Science & Business Media, 2013:245–52.10.1007/978-94-007-6591-7_24Search in Google Scholar
4. Mayer SK, Oligny LL, Deal C, Yazbeck S, Gagné N, et al. Childhood adrenocortical tumors: case series and reevaluation of prognosis-a 24-year experience. J Pediatr Surg 1997;32:911–5.10.1016/S0022-3468(97)90649-7Search in Google Scholar
5. Teinturier C, Pauchard MS, Brugières L, Landais P, Chaussain JL, et al. Clinical and prognostic aspects of adrenocortical neoplasms in childhood. Med Pediatr Oncol 1999;32:106–11.10.1002/(SICI)1096-911X(199902)32:2<106::AID-MPO7>3.0.CO;2-JSearch in Google Scholar
6. Michalkiewicz E, Sandrini R, Figueiredo B, Miranda EC, Caran E, et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol 2004;22:838–45.10.1200/JCO.2004.08.085Search in Google Scholar
7. Adrenal. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Green, FL, et al., editors. AJCC cancer staging manual, 7th ed. New York, NY: Springer, 2010:515–20.10.1007/978-0-387-88441-7_47Search in Google Scholar
8. Ribeiro RC, Pinto EM, Zambetti GP, Rodriguez-Galindo C. The international pediatric adrenocortical tumor registry initiative: contributions to clinical, biological, and treatment advances in pediatric adrenocortical tumors. Mol Cell Endocrinol 2012;351:37–43.10.1016/j.mce.2011.10.015Search in Google Scholar
9. Hagemann K, Zanolari Calderari M, Perren A, Cree I, Mullis PE, et al. A typical presentation of a hormonally active adrenocortical tumor in an adolescent leading to delayed diagnosis. Hormones 2011;10:317–25.10.14310/horm.2002.1324Search in Google Scholar
10. Ng L, Libertino JM. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 2003;169:5–11.10.1016/S0022-5347(05)64023-2Search in Google Scholar
11. Green AL, Srivatsa A, Rodriguez-Galindo C. Delayed diagnosis and false relapse due to paternal testosterone use in adrenocortical carcinoma. Pediatrics 2014;133:e1772–6.10.1542/peds.2013-1454Search in Google Scholar
12. Datrice NM, Langan RC, Ripley RT, Kemp CD, Steinberg SM. Operative management for recurrent and metastatic adrenocortical carcinoma. J Surg Oncol 2012;105:709–13.10.1002/jso.23015Search in Google Scholar
13. Garge S, Bawa M, Kanojia RP, Gupta K, Rao KL. A rare case of isolated Cushing syndrome in a 3-month-old boy. J Pediatr Endocrinol Metab 2013;26:599–603.10.1515/jpem.2011.343Search in Google Scholar
14. Liou LS, Kay R. Adrenocortical carcinoma in children. Review and recent innovations. Urol Clin North Am 2000;27:403–21.10.1016/S0094-0143(05)70089-6Search in Google Scholar
15. Hermsen IG, Gelderblom H, Kievit J, Romijn JA, Haak HR. Extremely long survival in six patients despite recurrent and metastatic adrenal carcinoma. Eur J Endocrinol 2008;158:911–9.10.1530/EJE-07-0723Search in Google Scholar PubMed
16. Children’s Oncology Group. ARAR0332: Treatment of adrenocortical tumors with surgery plus lymph node dissection and multiagent chemotherapy, A groupwise phase III study. Opened 9/18/2006.Search in Google Scholar
17. Wieneke JA, Thompson LD, Heffess CS. Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. Am J Surg Pathol 2003;27:867–81.10.1097/00000478-200307000-00001Search in Google Scholar PubMed
18. Berruti A, Baudin E, Gelderblom H, Haak HR, Porpiqlia F, et al. Adrenal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):vii131.10.1093/annonc/mds231Search in Google Scholar PubMed
19. Libé R, Bertherat J. Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. Eur J Endocrinol 2005;153:477–87.10.1530/eje.1.02004Search in Google Scholar PubMed
20. Gonzalez KD, Noltner KA, Buzin CH. Beyond Li Fraumeni syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 2009;27:1250–6.10.1200/JCO.2008.16.6959Search in Google Scholar PubMed
21. Trapp CM, Speiser PW, Oberfield SE. Congenital adrenal hyperplasia: an update in children. Curr Opin Endocrinol Diabetes Obes 2011;18:166–70.10.1097/MED.0b013e328346938cSearch in Google Scholar PubMed PubMed Central
©2016 by De Gruyter
